PL327657A1 - Macrocyclic compounds obtained from suboxide units - Google Patents

Macrocyclic compounds obtained from suboxide units

Info

Publication number
PL327657A1
PL327657A1 PL96327657A PL32765796A PL327657A1 PL 327657 A1 PL327657 A1 PL 327657A1 PL 96327657 A PL96327657 A PL 96327657A PL 32765796 A PL32765796 A PL 32765796A PL 327657 A1 PL327657 A1 PL 327657A1
Authority
PL
Poland
Prior art keywords
suboxide
units
compounds obtained
macrocyclic compounds
macrocyclic
Prior art date
Application number
PL96327657A
Other languages
English (en)
Inventor
Franz Dr Kerek
Original Assignee
Donatur Dr Kerek Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Donatur Dr Kerek Gmbh filed Critical Donatur Dr Kerek Gmbh
Publication of PL327657A1 publication Critical patent/PL327657A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
PL96327657A 1996-01-05 1996-12-30 Macrocyclic compounds obtained from suboxide units PL327657A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19600301A DE19600301C2 (de) 1996-01-05 1996-01-05 Durch Cyclooligomerisierung des einfachen Kohlensuboxids C¶3¶O¶2¶ aufgebaute makrocyclische Verbindungen, Verfahren zu deren Herstellung und Gewinnung sowie deren Verwendung
PCT/EP1996/005867 WO1997025333A2 (en) 1996-01-05 1996-12-30 Macrocyclic compounds made from suboxide units

Publications (1)

Publication Number Publication Date
PL327657A1 true PL327657A1 (en) 1998-12-21

Family

ID=7782233

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96327657A PL327657A1 (en) 1996-01-05 1996-12-30 Macrocyclic compounds obtained from suboxide units

Country Status (26)

Country Link
US (1) US6187810B1 (Direct)
EP (1) EP0874851B1 (Direct)
JP (1) JP4195089B2 (Direct)
KR (1) KR19990077000A (Direct)
CN (1) CN1209132A (Direct)
AR (1) AR005350A1 (Direct)
AT (1) ATE233768T1 (Direct)
AU (1) AU1307497A (Direct)
BG (1) BG102599A (Direct)
BR (1) BR9612430A (Direct)
CA (1) CA2241870A1 (Direct)
CZ (1) CZ208898A3 (Direct)
DE (2) DE19600301C2 (Direct)
EE (1) EE9800211A (Direct)
ES (1) ES2194128T3 (Direct)
HR (1) HRP970002A2 (Direct)
HU (1) HUP9904191A2 (Direct)
IL (1) IL125165A0 (Direct)
JO (1) JO1945B1 (Direct)
PL (1) PL327657A1 (Direct)
SI (1) SI0874851T1 (Direct)
SK (1) SK88598A3 (Direct)
TR (1) TR199801288T2 (Direct)
TW (1) TW376386B (Direct)
WO (1) WO1997025333A2 (Direct)
ZA (1) ZA9714B (Direct)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO280796A0 (en) * 1996-10-07 1996-10-31 Austin Research Institute, The Methods of activating or enhancing FC receptors
DE10260537A1 (de) 2002-12-21 2004-07-15 Kerek, Franz, Dr. Peptide mit hohem Cysteingehalt
US20060067055A1 (en) * 2004-09-30 2006-03-30 Heffner Kenneth H Thermally conductive composite and uses for microelectronic packaging
EP1794223A1 (en) * 2004-09-30 2007-06-13 Honeywell International Inc. Thermally conductive composite and uses for microelectronic packaging
CN119081077B (zh) * 2024-09-26 2025-12-26 清华大学 一种聚吡喃酮、制备方法及应用
CN119613750B (zh) * 2024-12-10 2025-08-12 杭州师范大学 一种机械及pH双重调控的蝶形钾离子通道分子及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2565115A (en) 1948-10-28 1951-08-21 Squibb & Sons Inc Method of obtaining a conjugated estrogen preparation
US2720483A (en) 1951-02-21 1955-10-11 Olin Mathieson Method of obtaining a conjugatedestrogen preparation

Also Published As

Publication number Publication date
ATE233768T1 (de) 2003-03-15
HUP9904191A2 (hu) 2000-05-28
HRP970002A2 (en) 1998-04-30
CA2241870A1 (en) 1997-07-17
BG102599A (en) 1999-03-31
AR005350A1 (es) 1999-04-28
TW376386B (en) 1999-12-11
DE69626548T2 (de) 2003-12-24
JP4195089B2 (ja) 2008-12-10
DE19600301A1 (de) 1997-07-10
JO1945B1 (en) 1997-12-15
JP2000503015A (ja) 2000-03-14
EP0874851B1 (en) 2003-03-05
TR199801288T2 (xx) 1998-11-23
BR9612430A (pt) 1999-12-28
WO1997025333A3 (en) 1997-12-24
US6187810B1 (en) 2001-02-13
CN1209132A (zh) 1999-02-24
AU1307497A (en) 1997-08-01
SK88598A3 (en) 1998-12-02
EE9800211A (et) 1998-12-15
IL125165A0 (en) 1999-01-26
EP0874851A2 (en) 1998-11-04
CZ208898A3 (cs) 1998-10-14
ES2194128T3 (es) 2003-11-16
SI0874851T1 (en) 2003-10-31
DE19600301C2 (de) 1999-12-09
DE69626548D1 (de) 2003-04-10
ZA9714B (en) 1997-07-23
KR19990077000A (ko) 1999-10-25
WO1997025333A2 (en) 1997-07-17

Similar Documents

Publication Publication Date Title
GB9614871D0 (en) Compounds
GB9607120D0 (en) Compounds
GB9616643D0 (en) Compounds
GB9602326D0 (en) Compounds
IL125165A0 (en) Macrocyclic compounds made from suboxide units
GB9612153D0 (en) Compounds
GB9606933D0 (en) Compounds
GB9614384D0 (en) Compounds
GB9615792D0 (en) Compounds
GB9614360D0 (en) Compounds
GB9607122D0 (en) Compounds
GB9607847D0 (en) Compounds
GB9618515D0 (en) Compounds
GB9613120D0 (en) Compounds
GB9618167D0 (en) Compounds
GB9617189D0 (en) Compounds
GB9618166D0 (en) Compounds
GB9607215D0 (en) Compounds
GB9618552D0 (en) Compounds
GB9618165D0 (en) Compounds
GB9613121D0 (en) Compounds
GB9607724D0 (en) Compounds
GB9600624D0 (en) Compounds
GB9610907D0 (en) Compounds
GB9618804D0 (en) Compounds